188 related articles for article (PubMed ID: 27011234)
1. Effects of Latanoprost and Bimatoprost on the Expression of Molecules Relevant to Ocular Inflow and Outflow Pathways.
Li X; He F; Gabelt BT; Wang Y; Cai S; Cao J; Fan N; Kaufman PL; Liu X
PLoS One; 2016; 11(3):e0151644. PubMed ID: 27011234
[TBL] [Abstract][Full Text] [Related]
2. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
Ota T; Aihara M; Narumiya S; Araie M
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
[TBL] [Abstract][Full Text] [Related]
3. Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells.
Ooi YH; Oh DJ; Rhee DJ
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5259-65. PubMed ID: 19443729
[TBL] [Abstract][Full Text] [Related]
4. Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases.
Yamada H; Yoneda M; Gosho M; Kato T; Zako M
BMC Ophthalmol; 2016 Mar; 16():26. PubMed ID: 26956170
[TBL] [Abstract][Full Text] [Related]
5. Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure-Lowering Effects of Latanoprost.
Roddy GW; Viker KB; Winkler NS; Bahler CK; Holman BH; Sheikh-Hamad D; Roy Chowdhury U; Stamer WD; Fautsch MP
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2715-2724. PubMed ID: 28538979
[TBL] [Abstract][Full Text] [Related]
6. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
Gagliuso DJ; Wang RF; Mittag TW; Podos SM
Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
[TBL] [Abstract][Full Text] [Related]
7. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
Gandolfi SA; Cimino L
Ophthalmology; 2003 Mar; 110(3):609-14. PubMed ID: 12623831
[TBL] [Abstract][Full Text] [Related]
8. Effect of prostaglandin analogs: Latanoprost, bimatoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human trabecular meshwork endothelial cells.
Heo JY; Ooi YH; Rhee DJ
Exp Eye Res; 2020 May; 194():108019. PubMed ID: 32222455
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Prostaglandin Analogues on the Ciliary Zonular Fibers of the Rabbit Crystalline Lens.
Hwang HB; Kim SY
Curr Eye Res; 2018 Nov; 43(11):1357-1361. PubMed ID: 30015523
[TBL] [Abstract][Full Text] [Related]
10. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R
J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
[TBL] [Abstract][Full Text] [Related]
11. Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism.
Hinz B; Rösch S; Ramer R; Tamm ER; Brune K
FASEB J; 2005 Nov; 19(13):1929-31. PubMed ID: 16076963
[TBL] [Abstract][Full Text] [Related]
12. Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide.
Richter M; Krauss AH; Woodward DF; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4419-26. PubMed ID: 14507888
[TBL] [Abstract][Full Text] [Related]
13. A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs.
Impagnatiello F; Borghi V; Gale DC; Batugo M; Guzzetta M; Brambilla S; Carreiro ST; Chong WK; Prasanna G; Chiroli V; Ongini E; Krauss AH
Exp Eye Res; 2011 Sep; 93(3):243-9. PubMed ID: 21356209
[TBL] [Abstract][Full Text] [Related]
14. A case hypersensitive to bimatoprost and dexamethasone.
Li X; Liu G; Wang Y; Yu W; Xiang H; Liu X
J Ocul Pharmacol Ther; 2011 Oct; 27(5):519-23. PubMed ID: 21936632
[TBL] [Abstract][Full Text] [Related]
15. Comparison of human ocular distribution of bimatoprost and latanoprost.
Ichhpujani P; Katz LJ; Hollo G; Shields CL; Shields JA; Marr B; Eagle R; Alvim H; Wizov SS; Acheampong A; Chen J; Wheeler LA
J Ocul Pharmacol Ther; 2012 Apr; 28(2):134-45. PubMed ID: 22136089
[TBL] [Abstract][Full Text] [Related]
16. A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.
Choplin N; Bernstein P; Batoosingh AL; Whitcup SM;
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S19-25. PubMed ID: 15016558
[TBL] [Abstract][Full Text] [Related]
17. Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues.
Yu AL; Fuchshofer R; Kampik A; Welge-Lüssen U
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4872-80. PubMed ID: 18971427
[TBL] [Abstract][Full Text] [Related]
18. Effect of travoprost, latanoprost and bimatoprost PGF2α treatments on the biomechanical properties of in-vivo rabbit cornea.
Wang J; Zhao Y; Yu A; Wu J; Zhu M; Jiang M; Li X; Zhu D; Zhang P; Zheng X; Bao F; Elsheikh A
Exp Eye Res; 2022 Feb; 215():108920. PubMed ID: 35007519
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma.
Sato S; Hirooka K; Baba T; Mizote M; Fujimura T; Tenkumo K; Ueda H; Shiraga F
J Ocul Pharmacol Ther; 2011 Oct; 27(5):499-502. PubMed ID: 21790301
[TBL] [Abstract][Full Text] [Related]
20. A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost.
Simmons ST; Bernstein P; Hollander DA
Am J Ophthalmol; 2008 Sep; 146(3):473-7. PubMed ID: 18561893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
